Changying Shi

1.2k total citations
37 papers, 1.0k citations indexed

About

Changying Shi is a scholar working on Molecular Biology, Polymers and Plastics and Biomaterials. According to data from OpenAlex, Changying Shi has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Polymers and Plastics and 12 papers in Biomaterials. Recurrent topics in Changying Shi's work include Dendrimers and Hyperbranched Polymers (13 papers), RNA Interference and Gene Delivery (12 papers) and Nanoparticle-Based Drug Delivery (9 papers). Changying Shi is often cited by papers focused on Dendrimers and Hyperbranched Polymers (13 papers), RNA Interference and Gene Delivery (12 papers) and Nanoparticle-Based Drug Delivery (9 papers). Changying Shi collaborates with scholars based in United States, China and Canada. Changying Shi's co-authors include Juntao Luo, Dandan Guo, Xu Wang, Gaofei Xu, Lili Wang, Yu Shao, Kai Xiao, Liqiong Cai, Wenzhe Huang and Lili Wang and has published in prestigious journals such as Nature Communications, Biomaterials and Cancer Research.

In The Last Decade

Changying Shi

35 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changying Shi United States 17 475 376 302 219 189 37 1.0k
Stefanie Wedepohl Germany 21 509 1.1× 426 1.1× 497 1.6× 224 1.0× 152 0.8× 52 1.3k
Iriny Ekladious United States 7 420 0.9× 265 0.7× 292 1.0× 151 0.7× 113 0.6× 12 799
Nate Larson United States 9 523 1.1× 320 0.9× 391 1.3× 157 0.7× 126 0.7× 10 878
Huaiyu Liu China 11 743 1.6× 408 1.1× 470 1.6× 139 0.6× 151 0.8× 13 1.1k
Sandro Sieber Switzerland 15 460 1.0× 462 1.2× 357 1.2× 128 0.6× 86 0.5× 18 1.2k
Gahininath Y. Bharate Japan 5 605 1.3× 389 1.0× 375 1.2× 119 0.5× 103 0.5× 7 993
Abby M. Gonik United States 5 766 1.6× 489 1.3× 511 1.7× 137 0.6× 157 0.8× 6 1.2k
Duhyeong Hwang United States 14 350 0.7× 309 0.8× 217 0.7× 157 0.7× 82 0.4× 25 875
Roghiyeh Pashaei‐Asl Iran 8 261 0.5× 466 1.2× 244 0.8× 131 0.6× 300 1.6× 15 1.0k
Libor Kostka Czechia 18 381 0.8× 382 1.0× 315 1.0× 188 0.9× 96 0.5× 47 925

Countries citing papers authored by Changying Shi

Since Specialization
Citations

This map shows the geographic impact of Changying Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changying Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changying Shi more than expected).

Fields of papers citing papers by Changying Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changying Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changying Shi. The network helps show where Changying Shi may publish in the future.

Co-authorship network of co-authors of Changying Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Changying Shi. A scholar is included among the top collaborators of Changying Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changying Shi. Changying Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Qinghe, Xiaojing Wang, Dandan Guo, et al.. (2025). Sparstolonin B nano-formulation attenuates LPS-induced lung injury. Frontiers in Pharmacology. 16. 1532391–1532391. 1 indexed citations
2.
Guo, Dandan, et al.. (2024). Telodendrimer functionalized hydrogel platform for sustained antibiotics release in infection control. Acta Biomaterialia. 178. 147–159. 8 indexed citations
3.
Guo, Dandan, et al.. (2024). “Click” amphotericin B in prodrug nanoformulations for enhanced systemic fungemia treatment. Journal of Controlled Release. 370. 626–642. 2 indexed citations
4.
Guo, Dandan, et al.. (2023). Engineering Nanotrap Hydrogel for Immune Modulation in Wound Healing. Macromolecular Rapid Communications. 44(23). e2300322–e2300322. 2 indexed citations
5.
Shi, Changying, et al.. (2023). Engineering Telodendrimer Nanocarriers for Monomeric Amphotericin B Delivery. Molecular Pharmaceutics. 20(4). 2138–2149. 7 indexed citations
6.
Guo, Dandan, et al.. (2020). Rationally Designed Micellar Nanocarriers for the Delivery of Hydrophilic Methotrexate in Psoriasis Treatment. ACS Applied Bio Materials. 3(8). 4832–4846. 21 indexed citations
7.
Shi, Changying, Xiaojing Wang, Lili Wang, et al.. (2020). A nanotrap improves survival in severe sepsis by attenuating hyperinflammation. Nature Communications. 11(1). 3384–3384. 58 indexed citations
8.
Wang, Lili, Changying Shi, Xu Wang, et al.. (2019). Zwitterionic Janus Dendrimer with distinct functional disparity for enhanced protein delivery. Biomaterials. 215. 119233–119233. 43 indexed citations
9.
Wang, Lili, Changying Shi, Forrest A. Wright, et al.. (2017). Multifunctional Telodendrimer Nanocarriers Restore Synergy of Bortezomib and Doxorubicin in Ovarian Cancer Treatment. Cancer Research. 77(12). 3293–3305. 39 indexed citations
10.
Wang, Xu, Changying Shi, Lili Wang, & Juntao Luo. (2017). Polycation-telodendrimer nanocomplexes for intracellular protein delivery. Colloids and Surfaces B Biointerfaces. 162. 405–414. 13 indexed citations
11.
12.
Huang, Wenzhe, Xu Wang, Changying Shi, et al.. (2015). Fine-Tuning Vitamin E-Containing Telodendrimers for Efficient Delivery of Gambogic Acid in Colon Cancer Treatment. Molecular Pharmaceutics. 12(4). 1216–1229. 41 indexed citations
13.
Xu, Gaofei, Changying Shi, Dandan Guo, et al.. (2015). Functional-segregated coumarin-containing telodendrimer nanocarriers for efficient delivery of SN-38 for colon cancer treatment. Acta Biomaterialia. 21. 85–98. 38 indexed citations
14.
Cai, Liqiong, Gaofei Xu, Changying Shi, et al.. (2014). Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment. Biomaterials. 37. 456–468. 129 indexed citations
15.
Zwingenberger, Allison L., et al.. (2011). Affinity of the alpha4–beta1 integrin-targeting peptide LLP2A to canine lymphoma. Veterinary Immunology and Immunopathology. 145(1-2). 298–304. 12 indexed citations
16.
Shi, Changying, Linna Guo, & Xiuyun Li. (2011). Effect of Jianwei yuyang capsule plus triad-therapy of western medicine on helicobacter pylori-related peptic ulcer in elderly. 18(21). 2893–2894. 1 indexed citations
17.
Zwingenberger, Allison L., William Vernau, Changying Shi, et al.. (2011). Development and characterization of 5 canine B-cell lymphoma cell lines. Leukemia Research. 36(5). 601–606. 5 indexed citations
18.
Xiao, Wenwu, Yan Wang, Edmond Y. Lau, et al.. (2010). The Use of One-Bead One-Compound Combinatorial Library Technology to Discover High-Affinity αvβ3 Integrin and Cancer Targeting Arginine-Glycine-Aspartic Acid Ligands with a Built-in Handle. Molecular Cancer Therapeutics. 9(10). 2714–2723. 63 indexed citations
19.
Chen, Wei, Meng Luo, Yongwei Sun, et al.. (2008). [Function of portal pressure during operation on the choice of surgical approaches in portal hypertension].. PubMed. 46(22). 1703–6. 1 indexed citations
20.
Chen, Jie, Zhenlin Liu, Huijuan Liu, et al.. (2002). [Study on occupational respiratory diseases in fur-processing workers].. PubMed. 20(1). 32–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026